Evidence map›Paper›PMID 26810227›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Interplay between Target Sequences and Repair Pathways Determines Distinct Outcomes of AID-Initiated Lesions.

Zhangguo Chen, Maxwell D Eder, Mihret T Elos, Sawanee S Viboolsittiseri, Xiaomi Chen, Jing H Wang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhangguo ChenDepartment of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045; and Department of Biomedical Research, National Jewish Health, Denver, CO 80206.
Maxwell D EderDepartment of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045; and.
Mihret T ElosDepartment of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045; and.
Sawanee S ViboolsittiseriDepartment of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045; and.
Xiaomi ChenDepartment of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045; and.
Jing H WangDepartment of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045; and Department of Biomedical Research, National Jewish Health, Denver, CO 80206 jing.wang@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USNational Jewish Health · US

Funding

Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
Mechanisms promoting translocations and mature B cell lymphomasR01CA166325 · NCI · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG · 2012 to 2016
$1.7M
Role of Target DNA sequences in mutation and DNA Break GenerationR21AI110777 · NIAID · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG · 2015 to 2016
$427k
Genomic instability mediated via differential DNA repair mechanisms in B cellsR21CA184707 · NCI · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG · 2015 to 2016
$372k
NCI NIH HHS 3R01CA166325-02S1NCI NIH HHS R01 CA166325NCI NIH HHS R01CA166325-01A1NCI NIH HHS R21 CA184707NCI NIH HHS R21CA184707-01A1NIAID NIH HHS R21 AI110777NIAID NIH HHS R21AI110777-01A1NIAID NIH HHS T32 AI074491
6 · The paper itself

Abstract

Activation-induced deaminase (AID) functions by deaminating cytosines and causing U:G mismatches, a rate-limiting step of Ab gene diversification. However, precise mechanisms regulating AID deamination frequency remain incompletely understood. Moreover, it is not known whether different sequence contexts influence the preferential access of mismatch repair or uracil glycosylase (UNG) to AID-initiated U:G mismatches. In this study, we employed two knock-in models to directly compare the mutability of core Sμ and VDJ exon sequences and their ability to regulate AID deamination and subsequent repair process. We find that the switch (S) region is a much more efficient AID deamination target than the V region. Igh locus AID-initiated lesions are processed by error-free and error-prone repair. S region U:G mismatches are preferentially accessed by UNG, leading to more UNG-dependent deletions, enhanced by mismatch repair deficiency. V region mutation hotspots are largely determined by AID deamination. Recurrent and conserved S region motifs potentially function as spacers between AID deamination hotspots. We conclude that the pattern of mutation hotspots and DNA break generation is influenced by sequence-intrinsic properties, which regulate AID deamination and affect the preferential access of downstream repair. Our studies reveal an evolutionarily conserved role for substrate sequences in regulating Ab gene diversity and AID targeting specificity.

Indexed as

Binding SitesDNA RepairNucleotide MotifsAICDA (Activation-Induced Cytidine Deaminase)AllelesAnimalsBase SequenceCytidine DeaminaseDNA Mismatch RepairGene Knock-In TechniquesGene OrderGene TargetingGenetic LociMiceMice, KnockoutMutationAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseMutS Homolog 2 ProteinUracil-DNA Glycosidase

Identifiers

PMID26810227
PMCPMC4760233
OpenAlexW2269664846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.